Shailesh Jejurikar, Chairman, President and CEO of Procter & Gamble Co, filed a Form 4 on October 26, 2026, disclosing transactions in common stock dated October 23, 2026, on NYSE:PG.

Key Highlights

  • Option exercise: Jejurikar acquired 35,000 shares of common stock via an option exercise (transaction code M) at an exercise price of $78.52 per share on October 23, 2026.
  • Sale of shares: 35,000 shares were disposed of (transaction code S) at a weighted average price of $163.0871, with the price range disclosed as $163.00 to $163.20.
  • Direct ownership after transactions: Jejurikar directly held 55,390.9973 shares of common stock following the reported transactions.
  • Remaining stock options: 70,170 stock options with a $78.52 exercise price and an expiration date of 02/28/2028 remained beneficially owned after the transaction.
  • Indirect holdings: Additional shares are held indirectly, including 3,777.6856 shares by a retirement plan trustee, 19,757 shares via the Sankhya S Jejurikar Revocable Trust, and 35,836 shares via the Shailesh Jejurikar Trust.

Jejurikar's October 23 Option Exercise and Stock Sale at Procter & Gamble

According to the Form 4 filed with the SEC on October 26, 2026, Shailesh Jejurikar, who serves as Chairman, President and CEO of Procter & Gamble Co (NYSE:PG), reported two transactions in the company's common stock on October 23, 2026. First, he exercised stock options to acquire 35,000 shares at an exercise price of $78.52 per share (transaction code M). The options, which became exercisable on 02/28/2021, carry an expiration date of 02/28/2028, and the price of the derivative security at exercise was reported as $0.

On the same date, the filing discloses, Jejurikar disposed of 35,000 shares (transaction code S) at a weighted average price of $163.0871. The filing notes that the price range for the sales was $163.00 to $163.20, and states that full information regarding the number of shares sold at each separate price is available upon request. Following both transactions, Jejurikar's direct beneficial ownership in common stock stood at 55,390.9973 shares, down from 90,390.9973 shares after the acquisition leg and before the sale.

The filing also reports indirect beneficial ownership in three categories: 3,777.6856 shares held by a retirement plan trustee, reflecting an adjustment to PST through September 30, 2026, as noted in the filing; 19,757 shares held through the Sankhya S Jejurikar Revocable Trust; and 35,836 shares held through the Shailesh Jejurikar Trust. After the reported option exercise, 70,170 stock options with the same $78.52 exercise price remained directly owned. The form was signed by Jennifer L. DollardSmith as attorney-in-fact for Shailesh Jejurikar and dated October 26, 2026.

What Was Disclosed

The filing reports that Procter & Gamble's Chairman, President and CEO exercised 35,000 stock options at $78.52 and sold 35,000 shares at a weighted average of $163.0871 on October 23, 2026, leaving direct ownership of 55,390.9973 shares and 70,170 remaining options.